Everett Harris & Co
- SEC CIK
- 0001009254
- Latest filing
- Aug 3, 2026
WST holding history
West Pharmaceutical Services Inc in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WST overviewAll 13F holders of WSTFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,982
- Value
- $1.07M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,982 | $1.07M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 2,982 | $747.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,982 | $820.5K | <0.1% | −275−8.4% | Reduced | Holders |
| Q3 2025 | 3,257 | $854.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,257 | $712.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,257 | $729.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,257 | $1.07M | <0.1% | −100−3.0% | Reduced | Holders |
| Q3 2024 | 3,357 | $1.01M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,357 | $1.11M | <0.1% | −400−10.6% | Reduced | Holders |
| Q1 2024 | 3,757 | $1.49M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,757 | $1.32M | <0.1% | −50−1.3% | Reduced | Holders |
| Q3 2023 | 3,807 | $1.43M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,807 | $1.46M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,807 | $1.32M | <0.1% | −100−2.6% | Reduced | Holders |
| Q4 2022 | 3,907 | $920.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,907 | $961.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,907 | $1.18M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,907 | $1.60M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 3,907 | $1.83M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,907 | $1.66M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,907 | $1.40M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,907 | $1.10M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.